Activin and Inhibin

BAY-8400 is an orally active, potent and selective DNA-dependent protein kinase ( DNA-PK ) inhibitor ( IC 50 =81 nM). BAY-8400 can be used for the research of cancerIn VivoBAY-8400 (150 mg/kg: p.o.) increases the antitumor efficacy. BAY-8400 shows

BAY-8400 is an orally active, potent and selective DNA-dependent protein kinase ( DNA-PK ) inhibitor ( IC 50 =81 nM). BAY-8400 can be used for the research of cancerIn VivoBAY-8400 (150 mg/kg: p.o.) increases the antitumor efficacy. BAY-8400 shows

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-85-8501 is a selective, reversible and potent inhibitor of Human Neutrophil Elastase (HNE) , with an IC 50 of 65 pM.In VivoIn this model the exogenous HNE noxa is the primary cause of injury and lung hemorrhage. Based on picomolar potency

BAY-850 is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC 50 of 166 nM.In VitroBAY-850 competes with the binding of a mono-acetylated Histone H4 N-terminal peptide to ATAD2 BD with an IC 50

BAY-850 is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC 50 of 166 nM.In VitroBAY-850 competes with the binding of a mono-acetylated Histone H4 N-terminal peptide to ATAD2 BD with an IC 50

BAY-850 is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC 50 of 166 nM.In VitroBAY-850 competes with the binding of a mono-acetylated Histone H4 N-terminal peptide to ATAD2 BD with an IC 50

BAY-850 is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC 50 of 166 nM.In VitroBAY-850 competes with the binding of a mono-acetylated Histone H4 N-terminal peptide to ATAD2 BD with an IC 50